Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
3. AngioDynamics picks up former SNN CEO
Just weeks after Smith & Nephew plc (NYSE:SNN) cut him loose, Joseph DeVivo picks up the top spot at AngioDynamics Inc. (NSDQ:ANGO).
2. The CRM slump proves worse than expected
The cardiac rhythm management industry looks like it needs of a jolt of its own, stat. A look at earnings filed by two of the market’s biggest players, Boston Scientific (NYSE:BSX) and St. Jude Medical (NYSE:STJ), reveals that the slump is worse that some industry observers thought.
1. Video: What keeps you up at night?
Some of the med-tech world’s top brass tells an audience at the MassDevice Big 100 Regional Roundtable about the biggest challenges the industry faces today. The panel includes ZOLL Medical Corp. (NSDQ:ZOLL) CEO Richard Packer, Good Start Genetics CEO Don hardison, IlluminOss Medical Inc. CEO Scott Rader and Semprus Biosciences CEO David Lucchino.
